Hallo,
die von Alti verbreiteten AdHocs News, die von 4Inverstors übernommen wurden,
sind inhaltlich nicht korrekt, irreführend und übertreiben eindeutig den Wert der Vereinbarung.
An instructive contrast
by: monkeyplay 01/31/05 11:58 pm
Msg: 28188 of 28189
The difference in content between the SPPI and Altair version’s of the PR are quite instructive of the sort o foutfit that Altair is:
This in SPPI’s version:
Spectrum will pay to Altair an upfront payment of 100,000 shares of restricted Spectrum common stock and will make an equity investment of $200,000 for 38,314 shares of Altair common stock.
Becomes THIS in Altair’s version:
Under the terms of the licensing agreement, an initial payment will be made consisting of restricted shares of Spectrum's common stock and a CASH PURCHASE BY SPECTRUM OF ALTAIR COMMON STOCK AT A 100 PERCENT PREMIUM to market price.
This in SPPI’s version:
In addition, Altair is eligible to receive payments upon achievement of a clinical development and certain regulatory and sales milestones, in addition to royalties on potential net sales.
Becomes THIS in Altair’s version:
Upon the successful completion of animal studies later this year confirming specified results, Spectrum will make an additional payment of restricted shares of Spectrum's common stock, for a projected total ***FIRST YEAR VALUE OF APPROXIMATELY $1.3 MILLION.***
And Altair just plain ADDED this to their version:
"[T]he total revenues to Altair over the life of this agreement could exceed $100 million."
|
Thread abonnieren
